Medi-546 clinical trials

Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus

This study is testing a new injection, anifrolumab, for adults aged 18-70 with moderate to severe lupus (SLE) in the UK. Researchers want to see if it's safe and helps improve symptoms when added to their usual lupus treatment. Half get the new drug, half get a dummy drug.